Investors comparing CLNE and WTW are weighing two very different market positions. Clean Energy Fuels is a renewable natural gas company tied to the energy transition and heavy-duty trucking adoption, while Willis Towers Watson is a global risk, benefits, and insurance advisory leader. This stock comparison is most relevant to traders and investors evaluating risk-adjusted relative performance: one side offers a volatile, policy-sensitive growth narrative, while the other offers steadier earnings and margin expansion. Understanding how each company is positioned in the current market environment helps clarify which business model offers more durable characteristics across changing economic conditions. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in their respective industries.
Clean Energy Fuels Corp. (CLNE) is a leading U.S. provider of renewable natural gas (RNG) for the transportation market, operating fueling stations and RNG production facilities. In recent weeks, the company reported quarterly revenue of $112.2 million, up 5.7% year over year, with adjusted earnings per share (EPS) of $0.03 beating analyst expectations. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) also exceeded forecasts, supported by Section 45Z clean fuel production credits and higher dairy RNG volumes.
Despite these improvements, sentiment remains cautious. The stock trades well below its 52-week high and remains loss-making under GAAP, with profitability dependent on regulatory credits and renewable fuel credit values. Management has acknowledged that adoption of the Cummins X15N natural gas engine in heavy-duty trucking has been slower than originally expected. The shares have also shown elevated volatility, with more than two dozen single-day moves of greater than 5% over the past year, reflecting both the company's small market capitalization and its sensitivity to policy and commodity-price dynamics.
Willis Towers Watson (WTW) is a global advisory, broking, and solutions firm spanning two segments: Health, Wealth & Career (HWC) and Risk & Broking (R&B). In its most recent quarter, the company reported revenue of roughly $2.46 billion, up 7.5% year over year, with adjusted EPS of $3.63 and adjusted operating margin of 21.9%, up 150 basis points. Net income was approximately $303 million, underscoring a consistently profitable, cash-generative business.
Sentiment toward WTW has been shaped by steady organic growth, margin execution, and the company's "Propel" AI (artificial intelligence) acceleration plan, which targets roughly $400 million in run-rate savings by the end of 2028. Analysts broadly rate the stock a "Buy," though some caution persists around softening commercial insurance pricing and periodic client attrition. Compared with CLNE, WTW's larger scale, diversified revenue base, and history of profitability contribute to meaningfully lower share-price volatility. From what I see, this steadier profile stands out when reviewing the fundamentals side by side.
The core contrast between these two stocks lies in business model and risk profile. CLNE is an energy-infrastructure growth story whose economics depend on fleet adoption of RNG trucks, regulatory credit values, and commodity spreads. WTW, by contrast, is a services business generating recurring advisory and broking fees across insurance and human-capital markets.
On growth drivers, CLNE's upside is tied to scaling RNG production and the X15N engine rollout, while WTW's is tied to organic revenue growth, margin expansion, and AI-driven efficiency. Recent momentum has favored WTW in terms of profitability and trend consistency; CLNE has shown larger swings following earnings and policy news. Risk factors also diverge: CLNE faces policy-credit and financing risk, whereas WTW faces a softer insurance pricing cycle and execution risk around its transformation plan. Sector exposure reinforces the divide, with CLNE exposed to energy and transportation and WTW to financial and professional services. These differences mean the two stocks rarely appeal to the same investor for the same reasons. I’m watching this closely because the divergence in volatility and earnings stability is quite pronounced.
Based on observable factors such as trend consistency, earnings stability, margin trajectory, and relative volatility, Tickeron's AI would likely favor WTW over CLNE in the current environment. WTW's profitable and cash-generative model, expanding operating margins, and steadier price behavior present a more consistent technical and fundamental profile. CLNE's improving results and policy tailwinds are notable, but its GAAP losses, elevated volatility, and dependence on credit economics introduce greater uncertainty. Accordingly, the AI verdict leans toward WTW for stability and trend quality, while acknowledging that CLNE may offer higher-risk, catalyst-driven upside for investors with a more speculative orientation.
One resource I turn to regularly when evaluating stocks like these is Tickeron’s AI Trading Bots, which monitor and trade thousands of different tickers with varying strategies and timeframes. The platform curates the most effective and currently relevant approaches in its Trending AI Robots section, making it easier to identify signal-based ideas without reviewing every option manually. Whether focusing on short-term momentum or longer-horizon positioning, this curated view offers a practical starting point for understanding how automated strategies are performing in real time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day RSI Oscillator for CLNE moved out of overbought territory on November 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In 24 of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLNE as a result. In 78 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for CLNE turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 42 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
CLNE moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLNE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
CLNE broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for CLNE crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +8.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLNE advanced for three days, in 175 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 98 of 146 cases where CLNE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.761) is normal, around the industry mean (4.566). CLNE has a moderately low P/E Ratio (-4.442) as compared to the industry average of (10.639). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (1.079). Dividend Yield (0.000) settles around the average of (0.067) among similar stocks. P/S Ratio (0.844) is also within normal values, averaging (0.549).
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. CLNE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLNE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 44, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of natural gas fuel transportation services
Industry OilRefiningMarketing